Statistics on Biotechnology Use  
Results by sector of operation
Sector Companies. Results in biotechnology for main variables and branches of activity 
Unidades: specified in variables

,Total Companies,Services,Industry and Construction,Agriculture,
No. of companies carrying out R&D in Biotechnology,1.133,722,333,79,
%Companies according to biotechnology used: Genetic code,33,40,19,32,
%Companies according to biotechnology used: Functional units,41,45,38,23,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,24,28,15,26,
%Companies according to biotechnology used: Bioprocesses,50,39,76,35,
%Companies according to biotechnology used: Sub-cellular organisms,6,8,2,0,
%Companies according to biotechnology used: Bio-computing,24,33,9,11,
%Companies according to biotechnology used: Nanobiotechnology,13,16,8,4,
%Companies according to biotechnology used: Other,14,16,8,30,
Companies in which biotechnology activities are: Main and/or exclusive,603,490,99,15,
Companies in which biotechnology activities are: A secondary line of business,173,97,60,16,
Companies in which biotechnology activities are: A tool necessary for production,357,135,175,48,
%Company by field(s) of ultimate application of biotechnology use: Human Health,45,59,24,6,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,18,20,11,27,
%Company by field(s) of ultimate application of biotechnology use: Food products,31,23,51,23,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,22,20,18,62,
%Company by field(s) of ultimate application of biotechnology use: Environment,14,13,15,14,
%Company by field(s) of ultimate application of biotechnology use: Industry,12,14,12,1,
Personnel in R&D in biotechnology (no. of persons),11.510,7.769,3.054,687,
Personnel in R&D in biotechnology (no. of persons): Researchers,6.202,4.554,1.408,241,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,5.308,3.215,1.646,446,
Personnel in R&D in biotechnology (no. of persons): women,6.389,4.518,1.543,328,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,3.304,2.434,754,115,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,3.086,2.084,789,213,
Personnel in R&D in biotechnology (FTE),8.236,9,5.941,7,1.868,5,426,7,
Personnel in R&D in biotechnology (FTE): Researchers,4.596,1,3.468,7,963,3,164,1,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,3.640,8,2.473,905,3,262,6,
Personnel in R&D in biotechnology (FTE): women,4.698,5,3.453,1.020,7,224,9,
Personnel in R&D in biotechnology (FTE): (women) Researchers,2.512,5,1.878,4,557,4,76,6,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,2.186,1.574,5,463,3,148,2,
Internal expenditure on R&D (thousands of euros),769.431,533.657,201.922,33.852,
1) By nature of the expense: Current expenses,719.715,504.270,185.577,29.868,
1.1) Remuneration to researchers,221.447,149.223,64.648,7.576,
1.2) Remuneration to technicians and assistants,122.809,75.033,41.097,6.679,
1.3) Other current expenses,375.459,280.014,79.832,15.614,
2) By nature of the expense: Capital expenses,49.715,29.387,16.345,3.984,
2.1) Land and buildings,9.521,3.329,4.506,1.687,
2.2) Equipment and instruments,30.466,18.712,9.484,2.269,
2.3) Acquisition of specific R&D software,1.810,1.279,508,23,
2.4) Otros productos de propiedad intelectual específicos para I+D,7.919,6.066,1.847,5,
1.1) By origin of the funds: Own funds,490.913,304.305,156.340,30.268,
1.2) By origin of the funds: From companies,82.548,76.853,5.695,0,
1.3) By origin of the funds: Public Administration funds,96.809,83.993,11.520,1.296,
1.4) By origin of the funds: From Universities,197,185,12,0,
1.5) By origin of the funds: From non profit private institutions,4.766,4.766,0,0,
1.6) By origin of the funds: Foreign funds,94.197,63.555,28.355,2.288,
Purchase of R&D services in biotechnology (thousands of euros),120.281,60.387,59.506,389,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,69.564,15.873,53.360,331,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,50.718,44.514,6.146,58,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,45,54,27,41,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,12,11,16,13,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,16,16,16,15,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,14,15,12,9,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,16,19,11,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,18,21,13,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,15,16,13,20,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,37,38,33,37,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,52,56,42,57,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,20,21,15,29,
% Companies that have requested biotechnology patents in Biotechnology,15,17,11,6,
Number of patents requested,681,493,154,34,
% Companies with income of an international origin related to biotechnological activities,24,3,29,18,4,6,4,
% Turnover representing income of an international origin related to biotechnological activities,1,4,1,0,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,59,6,46,8,62,9,94,5,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,40,4,53,2,37,1,5,5,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,80,4,69,2,83,4,99,3,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,16,5,17,16,4,0,
% Income of an international origin related with activities according to the classification: Operating source abroad,2,2,9,7,0,2,0,7,
% Income of an international origin related with activities according to the classification: Other,0,9,4,1,0,0,
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute